1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with B16 Melanoma in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Hassani, M; Althouse, SK; Ferracini, M; Harrison, KA; Konger, RL; Loesch, M; Murphy, RC; Ocana, JA; Perkins, SM; Sahu, RP; Speicher, PJ; Sun, L; Touloukian, CE; Travers, JB; Tyler, DS | 1 |
| Ferracini, M; Sahu, RP; Travers, JB | 1 |
| Im, SY; Kim, HA; Kim, KJ; Lee, HK; Yoon, SY | 1 |
| DaSilva, SC; Kaplan, MH; Konger, RL; Ocana, JA; Perkins, SM; Rashid, BM; Sahu, RP; Touloukian, CE; Travers, JB; Turner, MJ | 1 |
| Im, SY; Kim, HA; Kim, KJ; Lee, HK; Seo, KH | 1 |
| Biancone, L; Camussi, G; Cantaluppi, V; Del Sorbo, L; Russo, S; Tjoelker, LW | 1 |
| Choi, JH; Heon Seo, K; Im, SY; Jun Park, S; Kim, HA; Kim, KJ; Ko, HM; Lee, HK | 1 |
| Im, SY; Jung, B; Kang, JH; Kang, YR; Kim, HA; Kim, KJ; Ko, HM; Lee, HK; Park, SJ | 1 |
| Bai, S; Chun, SB; Chung, KC; Ha, TY; Im, SY; Kang, HS; Kim, JW; Ko, HM; Lee, HB; Lee, HK; Lee, YB; Oh, SJ | 1 |
| Ikuta, K; Ishii, S; Kume, K; Miyazaki, J; Nagase, T; Sato, S; Shimizu, T; Tashiro, F; Waga, I | 1 |
10 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and B16 Melanoma
| Article | Year |
|---|---|
Chemotherapeutic agents subvert tumor immunity by generating agonists of platelet-activating factor.
Topics: Animals; Antineoplastic Agents; Antioxidants; Cell Line, Tumor; Cyclooxygenase 2 Inhibitors; Female; Glycerylphosphorylcholine; Humans; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Oxidative Stress; Platelet Activating Factor; Platelet Membrane Glycoproteins; Reactive Oxygen Species; Receptors, G-Protein-Coupled; Signal Transduction; T-Lymphocytes, Regulatory | 2014 |
Systemic chemotherapy is modulated by platelet-activating factor-receptor agonists.
Topics: Animals; Antineoplastic Agents; Antioxidants; Etoposide; Female; Immunosuppression Therapy; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasm Transplantation; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Signal Transduction | 2015 |
Glutamine inhibits platelet-activating factor-mediated pulmonary tumour metastasis.
Topics: Animals; Cell Line, Tumor; Female; Glutamine; JNK Mitogen-Activated Protein Kinases; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Neovascularization, Pathologic; Platelet Activating Factor | 2012 |
The environmental stressor ultraviolet B radiation inhibits murine antitumor immunity through its ability to generate platelet-activating factor agonists.
Topics: Animals; Melanoma, Experimental; Mice; Platelet Activating Factor; Real-Time Polymerase Chain Reaction; T-Lymphocytes, Regulatory; Ultraviolet Rays | 2012 |
PTEN/MAPK pathways play a key role in platelet-activating factor-induced experimental pulmonary tumor metastasis.
Topics: Androstadienes; Animals; Anthracenes; Butadienes; Cell Line; Humans; Imidazoles; Lung Neoplasms; MAP Kinase Signaling System; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Nitriles; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Platelet Activating Factor; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Pyridines; Wortmannin | 2012 |
Platelet-activating factor inactivation by local expression of platelet-activating factor acetyl-hydrolase modifies tumor vascularization and growth.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Base Sequence; Cell Division; Cell Line, Tumor; Cell Movement; Chemotaxis; DNA Primers; Humans; Melanoma, Experimental; Mice; Neovascularization, Pathologic; Platelet Activating Factor; Recombinant Proteins; RNA, Messenger; Transfection | 2003 |
Platelet-activating factor induces up-regulation of antiapoptotic factors in a melanoma cell line through nuclear factor-kappaB activation.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; bcl-X Protein; Caspase Inhibitors; Caspases; Cell Line, Tumor; Drug Interactions; Etoposide; Female; Melanoma, Experimental; Mice; Mice, Inbred C57BL; NF-kappa B; Platelet Activating Factor; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Sesquiterpenes; Up-Regulation | 2006 |
Critical role for matrix metalloproteinase-9 in platelet-activating factor-induced experimental tumor metastasis.
Topics: Animals; Lung Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; NF-kappa B; Platelet Activating Factor; Skin Neoplasms; Transcription Factor AP-1 | 2007 |
Augmentation of tumor metastasis by platelet-activating factor.
Topics: Animals; Antineoplastic Agents; Azepines; Female; Interleukin-1; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Platelet Activating Factor; Triazoles; Tumor Necrosis Factor-alpha | 1996 |
Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor.
Topics: Animals; Bronchial Hyperreactivity; Bronchoconstrictor Agents; Endotoxins; Female; Fertility; Guinea Pigs; Male; Melanoma, Experimental; Methacholine Chloride; Mice; Mice, Transgenic; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Sex Ratio; Shock, Septic; Skin Neoplasms | 1997 |